Showing results (131-140 of 251) with videos related to
Sort By:
Pageof 26
Diabetes Research and Clinical Practice|July 3, 1998
Salt sensitivity: concept and pathogenesisO González-Albarrán, L M Ruilope, E Villa, et al.Nephron|January 1, 1991
Does calcium antagonist improve established early ciclosporin nephrotoxicity after renal transplantation?J M Morales, A Andres, C Montoyo, et al.Blood Pressure|September 23, 2011
A review of renal, cardiovascular and mortality endpoints in antihypertensive trials in diabetic patientsJ A García-Donaire, J Segura, C Cerezo, et al.Journal of Human Hypertension|May 3, 2013
Interpreting treatment-induced blood pressure reductions measured by ambulatory blood pressure monitoringR E Schmieder, L M Ruilope, C Ott, et al.Hipertension Y Riesgo Vascular|August 19, 2020
[Awareness, treatment and control of blood pressure according to place of recruitment and sex in the May Measure Month 2018 survey in Spain]T Gijón-Conde, E Rodilla, A Molinero, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 18, 1997
Elevation of von Willebrand factor levels in patients with IgA nephropathy: effect of ACE inhibitionE Hernández, T Toledo, C Alamo, et al.Revista Espanola De Fisiologia|March 1, 1979
Alterations induced by large doses of furosemide in chronic renal insufficiencyA Barrientos, L Ruilope, D Jarillo, et al.Revista Espanola De Fisiologia|March 1, 1978
Aldosterone regulation in anephric patientsL M Ruilope, S Casado, L Hernando, et al.Journal of the American College of Cardiology|December 12, 2001
Renal function: the Cinderella of cardiovascular risk profileL M Ruilope, D J van Veldhuisen, E Ritz, et al.Blood Pressure|February 24, 2001
Comparative study of home and office blood pressure in hypertensive patients treated with enalapril/HCTZ 20/6 mg: the ESPADA studyC Campo, G Fernández, J González-Esteban, et al.Pageof 26